COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • September 29th, 2008 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • Texas
Contract Type FiledSeptember 29th, 2008 Company Industry JurisdictionThis COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), is made as of September 29, 2008 by and between Repros Therapeutics Inc., a Delaware corporation, with its principal executive offices located at 2408 Timberloch Place, Suite B-7, The Woodlands, Texas 77380 (the “Company”), and Cyan Opportunities Fund, Ltd. (the “Investor”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • September 29th, 2008 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • Texas
Contract Type FiledSeptember 29th, 2008 Company Industry JurisdictionThis COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), is made as of September 29, 2008 by and between Repros Therapeutics Inc., a Delaware corporation, with its principal executive offices located at 2408 Timberloch Place, Suite B-7, The Woodlands, Texas 77380 (the “Company”), and John C. Reed (the “Investor”).